| (N=658) * |
|
n |
Percentage (%) |
| Ethnic group |
Wolof
Fulani
Mandinka |
201/643
234/643
208/643 |
31.26
36.39
32.35 |
| Age |
<5 years
5-15 years
>15 years |
133/637
270/637
234/637 |
20.88
42.39
36.73 |
| CSP antibodies† |
negative
positive |
146/628
482/628 |
23.25
76.75 |
| MSP119 antibodies ‡ |
negative
positive |
225/630
405/630 |
35.71
64.29 |
| AMA1 antibodies § |
negative
positive |
315/630
315/630 |
0.00
50.00 |
| Sex |
male
female |
280/654
374/654 |
42.81
57.19 |
| Net ownership |
no
yes |
494/658
164/658 |
75.08
24.92 |
| Net impregnated with insecticide |
no
yes |
651/658
7/658 |
98.94
1.06 |
| Entomological inoculation rate (EIR) |
0
≤ 50
>50 |
90/606
409/606
107/606 |
14.85
67.49
17.66 |
| G6PD deficiency¶ |
Not deficient
A- heterozygote
A- |
533/565
25/565
7/565 |
94.34
4.42
1.24 |
| Sickle-cell disease |
AA
AS
SS |
467/592
118/592
7/592 |
78.89
19.93
1.18 |
| Eaves gap in the household |
no
yes |
305/658
353/658 |
46.35
53.65 |
| Malaria treatment in the 30 days before cross 1 |
no
yes |
408/606
198/606 |
67.33
32.67 |
| Malaria treatment in the 30 days before cross 2 |
no
yes |
01/587
186/587 |
68.31
31.69 |
| *Number of subjects included in the analysis; †CSP: Circumsporozoite Surface Protein; ‡MSP119: Conserved C terminal region of Merozoite Surface Protein 1; §AMA1: Apical Membrane Antigen 1; ¶G6PD: Glucose-6-phosphate dehydrogenase; This information is not strictly baseline data. |
